For patients suffering from bacterial infections of the blood, identifying microbes and measuring their antibiotic susceptibility as quickly as possible is essential. The Lewis Research Group has developed a new metabolomics-based test that delivers this critical information 2.5 times faster than existing testing methods. Check out the article by UCalgary’s Mark Lowey featuring this revolutionary, life-saving technology, and read up on the approach in the recently published Nature Communications article.